Suffered its worst trading session in 15 years. The ruble bounced back at the open this morning, but it has since dropped once again, falling into negative territory against the dollar despite these extremely hard core moves by the russians. Russian stocks selling up again as Oil Continues to decline. Michelle ka reduce sa cabrera will join us with the russian story and why the markets are very worried in just a moment. Headlines out of china grabbing attention this morning. The first flash reading of the hsbc pmi showing the First Manufacturing contraction there in seven months. It was a reading below 50. This is the latest sign of weakness in the chinese economy. Stocks rose on hopes of more stimulus from chinas central bank. As for how things are shaping up here at home, check out the futures this morning. At least in early trading, remember yesterday, everything reversed by the end of the day. We were up 100 points in premarket. But in the premarket this morning, dow futures are in
The senate acts . And which companies could benefit big time. All that and more tonight on nightly Business Report for monday, november 17th. Good evening, everyone. A big day for big deals today. The buzz on wall street was all about two blockbuster mergers, one in the Energy Sector. Well have more on that in a moment. The other in the health care sector. We begin with the bigger of the two deals, generic drugmaker actavis agreeing to pay 66 billion for allergan, the maker of botox. The massive price tag which amounts to 219 per share effectively ends a monthlong hostile bid by Hedge Fund Manager bill ackman along with canadian drugmaker valeant for the same company. Investors approved. Shares of actavis rose while allergan jumped 5 . More now on how actavis sealed the deal. The bidding war for botoxmaker allergan didnt end up quite the way actavis investor bill ackman had been hoping for. More potential partners or combination partners say theyre not interested in allergan puts valea
What will the president do if the senate acts . And which companies could benefit big time. All that and more tonight on nightly Business Report for monday, november 17th. Good evening, everyone. A big day for big deals today. The buzz on wall street was all about two blockbuster mergers, one in the Energy Sector. Well have more on that in a moment. The other in the health care sector. We begin with the bigger of the two deals, generic drugmaker actavis agreeing to pay 66 billion for allergan, the maker of botox. The massive price tag which amounts to 219 per share effectively ends a monthlong hostile bid by Hedge Fund Manager bill ackman along with canadian drugmaker valeant for the same company. Investors approved. Shares of actavis rose while allergan jumped 5 . More now on how actavis sealed the deal. The bidding war for botoxmaker allergan didnt end up quite the way actavis investor bill ackman had been hoping for. More potential partners or combination partners say theyre not int
What will the president do if the senate acts . And which companies could benefit big time. All that and more tonight on nightly Business Report for monday, november 17th. Good evening, everyone. A big day for big deals today. The buzz on wall street was all about two blockbuster mergers, one in the Energy Sector. Well have more on that in a moment. The other in the health care sector. We begin with the bigger of the two deals, generic drugmaker actavis agreeing to pay 66 billion for allergan, the maker of botox. The massive price tag which amounts to 219 per share effectively ends a monthlong hostile bid by Hedge Fund Manager bill ackman along with canadian drugmaker valeant for the same company. Investors approved. Shares of actavis rose while allergan jumped 5 . More now on how actavis sealed the deal. The bidding war for botoxmaker allergan didnt end up quite the way actavis investor bill ackman had been hoping for. More potential partners or combination partners say theyre not int
The senate acts . And which companies could benefit big time. All that and more tonight on nightly Business Report for monday, november 17th. Good evening, everyone. A big day for big deals today. The buzz on wall street was all about two blockbuster mergers, one in the Energy Sector. Well have more on that in a moment. The other in the health care sector. We begin with the bigger of the two deals, generic drugmaker actavis agreeing to pay 66 billion for allergan, the maker of botox. The massive price tag which amounts to 219 per share effectively ends a monthlong hostile bid by Hedge Fund Manager bill ackman along with canadian drugmaker valeant for the same company. Investors approved. Shares of actavis rose while allergan jumped 5 . More now on how actavis sealed the deal. The bidding war for botoxmaker allergan didnt end up quite the way actavis investor bill ackman had been hoping for. More potential partners or combination partners say theyre not interested in allergan puts valea